Anebulo Pharmaceuticals Inc (ANEB)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current ANEB market cap is 37.86M. The company's latest EPS is USD -0.3163 and P/E is -4.62.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.54M | -2.76M | -1.66M | -1.34M | -2.41M |
| Net Income | -2.48M | -2.72M | -1.65M | -1.35M | -2.2M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -174k | -3.61M | -6.83M | -11.78M | -8.31M |
| Net Income | -175k | -38.46M | -6.83M | -11.73M | -8.2M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 9.05M | 7.5M | 6M | 4.07M | 2.47M |
| Total Liabilities | 717k | 1.01M | 1.01M | 260k | 569k |
| Total Equity | 8.33M | 6.49M | 4.99M | 3.81M | 1.9M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.03M | 21.65M | 15.58M | 11.67M | 4.07M |
| Total Liabilities | 224k | 242k | 513k | 1.07M | 260k |
| Total Equity | -171k | 21.41M | 15.07M | 10.6M | 3.81M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.73M | -4.54M | -6.04M | -8.09M | -1.69M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | -62k | -62k | -62k | N/A |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -151k | -4.87M | -5.44M | -9.68M | -8.09M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 3.18M | 21.83M | N/A | 6.38M | -62k |
| Market Cap | 37.86M |
| Price to Earnings Ratio | -4.62 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 12.24 |
| Price to Book Ratio | 9.93 |
| Dividend Yield | - |
| Shares Outstanding | 25.93M |
| Average Volume (1 week) | 8.88k |
| Average Volume (1 Month) | 80.37k |
| 52 Week Change | -41.83% |
| 52 Week High | 3.30 |
| 52 Week Low | 0.8001 |
| Spread (Intraday) | 0.38 (23.75%) |
| Company Name | Anebulo Pharmaceuticals Inc |
| Address |
838 walker road dover, delaware 19904 |
| Website | https://www.anebulo.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
